Mission statement · Company scope
“Our mission is to revolutionize the treatment of solid tumors with a single dose of engineered TCR T-cells and as a result to address cancers with high unmet needs.”
In use2025 – now1 sighting
First seenMar 2025Added
Last seenMar 2025Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary) · Problem–solution
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Technical
- Length
- 29 words · reading grade 13.8
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_25a607c4a79528df
- Classification confidence
- 0.67
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2025-03-24 · sec_sentence · 10-K · accession 0001558370-25-003544
View filing ↗0 to compareCompare